C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2592176
Correlations between polymorphisms and metabolic syndrome, obesity, treatment- emergent weight gain and insulin resistance are provided. Methods of diagnosing and treating metabolic syndrome, obesity, treatment-emergent weight gain and insulin resistance are provided. Systems and kits for diagnosis and treatment of metabolic syndrome, obesity, treatment-emergent weight gain and insulin resistance are provided.
L'invention concerne des corrélations entre des polymorphismes et le syndrome métabolique, l'obésité, la prise de poids consécutive à un traitement et la résistance à l'insuline. L'invention concerne également des méthodes permettant de diagnostiquer et de traiter le syndrome métabolique, l'obésité, la prise de poids consécutive à un traitement et la résistance à l'insuline. L'invention concerne enfin des systèmes et des trousses permettant de diagnostiquer et de traiter le syndrome métabolique, l'obésité, la prise de poids consécutive à un traitement et la résistance à l'insuline.
Ballinger Dennis
Cox David
Hockett Richard
Kirkwood Sandra
Fetherstonhaugh & Co.
Perlegen Sciences Inc.
LandOfFree
Markers for metabolic syndrome obesity and insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Markers for metabolic syndrome obesity and insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers for metabolic syndrome obesity and insulin resistance will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1941075